Login
$AHCO
$5.93 -$0.09 (1.5%) Close

$AHCO SEC Filings

Filed On Filing
13 Oct 2026 SCHEDULE 13G/A
08 Oct 2026 SCHEDULE 13G/A
11 Sep 2026 Form 4: Currie Harriss T, CHIEF FINANCIAL OFFICER

Received 141,372 shares as a grant or award

11 Sep 2026 Form 3: Currie Harriss T, CHIEF FINANCIAL OFFICER

Holds 0 shares of Common Stock

08 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of this 7th day of September 2026, by and between AdaptHealth Corp., a Delaware corporation (the “Company”), and Harriss T. Currie (“Executive”).

14 Aug 2026 Form 4/A: Wolf Dale B, Director

Bought 20,000 shares ($126K)

10 Aug 2026 Form 4: Samet Kenneth A, Director

Bought 23,500 shares ($150K)

10 Aug 2026 Form 4: Wolf Dale B, Director

Bought 20,000 shares ($127K) · Bought 20,000 shares ($117K)

04 Aug 2026 10-Q
04 Aug 2026 8-K: Results of Operations and Financial Condition
20 Jul 2026 8-K: Entry into a Material Definitive Agreement
07 Jul 2026 8-K: Regulation FD Disclosure
06 Jul 2026 Form 4: Schuster Iii Russell E., Chief Commercial Officer

Sold 11,275 shares ($118K)

02 Jul 2026 8-K: Material Cybersecurity Incidents
01 Jul 2026 144
26 Jun 2026 Form 4: Williams David Solomon Iii, Director

Received 18,999 shares as a grant or award

26 Jun 2026 Form 4: Weaver Susan T, Director

Received 18,999 shares as a grant or award

26 Jun 2026 Form 4: Connors Terence J, Director

Received 18,999 shares as a grant or award

26 Jun 2026 Form 4: Belinfanti Gregory, Director

Received 18,999 shares as a grant or award

26 Jun 2026 Form 4: Coppens Bradley J, Director

Received 18,999 shares as a grant or award

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support